term stringlengths 2 121 | overlap int64 6 281 | setsize int64 7 499 | score float64 1.96 10.6 | pval float64 0 0.05 | edge stringlengths 41 1.97k | type stringclasses 5
values | subtype stringclasses 24
values | subtype_key stringclasses 24
values | edge_idxs stringlengths 11 1.17k | ann_idxs stringlengths 19 2.31k | ann_vals stringlengths 124 9.94k | sig_size int64 2.2k 3.73k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glycosyltransferase | 7 | 31 | 2.270384 | 0.023184 | Q9BT22,P43490,Q13126,O43505,Q10472,P04062,Q2TAA5 | Functions | Protein Atlas Molecular function | protein_atlas_molecular_function | 292,257,41,87,308,56,222 | 709,87,2286,1572,1998,2169,56,1139,2494,1460,2762,1812,1041,1935,257,686,2356,1428,654,308,41,222,1285,1286,1235,908,410,292,1788,2157,1739 | 0.5158731784643796,2.3478963961729225,-0.3724389183184647,-0.02190402285820215,-0.2236212584096826,-0.31242291199836886,2.888427682882454,0.22681944749468783,-0.49448594888254555,0.03437193328851483,-0.7148241860051961,-0.1362485904097433,0.2805565672472788,-0.19434031752410985,1.2095131214680288,0.5413858311413456,-0.... | 3,367 |
Regulation of blood pressure | 6 | 17 | 2.267809 | 0.023341 | Q9UIQ6,P42892,P42785,P09601,Q9HB40,Q9NZ08 | Processes and pathways | GO Biological process | msigdb_gobp | 228,35,18,21,58,156 | 3328,2922,1213,21,3162,927,18,35,512,1328,234,1227,2785,58,156,228,844 | -2.131961245664126,-0.8777714879158465,0.17253621044918402,3.613683844728898,-1.2539690378581203,0.3601597156898264,3.8282095648532786,3.2722740469256966,0.7165975954483155,0.11769676093724667,1.2983027806935246,0.17253621044918402,-0.7148241860051961,2.840232108692598,1.7406977485275759,1.3421283755465698,0.4385882859... | 3,367 |
Hormone metabolic process | 8 | 26 | 2.266413 | 0.023426 | P42892,O75844,P16435,Q9UBM7,Q9HB40,O95470,P30536,Q14849 | Processes and pathways | GO Biological process | msigdb_gobp | 35,68,293,185,58,123,124,31 | 1927,68,123,1213,1930,2763,293,124,35,3279,1586,2660,3114,31,1277,351,582,1017,1237,2030,2603,3152,58,185,2967,2281 | -0.19434031752410985,2.6926945390869426,1.9771403969263128,0.17253621044918402,-0.19434031752410985,-0.7148241860051961,1.0963292676298746,1.9771403969263128,3.2722740469256966,-1.6192482414532234,-0.02190402285820215,-0.6193116841420223,-1.1488380282478365,3.3454673481684774,0.1451866537146581,0.9806125526787869,0.642... | 3,367 |
Neuronal loss in central nervous system | 6 | 11 | 2.25608 | 0.024066 | O15118,P07602,Q9NZJ7,P35637,Q9BTW9,P04062 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 96,113,641,332,639,56 | 96,1455,1753,56,113,1635,332,999,662,639,641 | 2.2759315653971224,0.03437193328851483,-0.1074347923116181,2.888427682882454,2.110076974296961,-0.050263952997597124,1.0039634351651625,0.30722341578558393,0.5667757956444454,0.5920441322650274,0.5920441322650274 | 3,367 |
Apical plasma membrane | 20 | 39 | 2.252807 | 0.024271 | P15311,P04083,Q15043,P08183,P35241,O75955,O75970,P41440,P54709,Q86UE4,P21281,P53985,Q9Y4G8,Q16625,Q14254,P26038,Q99808,P30825,Q9P289,P08238 | Localization | GO Cellular component | msigdb_gocc | 630,753,263,146,531,528,784,167,792,171,548,553,59,188,691,451,470,85,642,754 | 1990,961,1924,528,784,753,1213,146,1091,1265,754,1215,2923,630,1042,927,548,451,85,531,970,2291,2498,167,553,792,2236,2502,1226,2361,691,263,822,188,171,470,2159,642,59 | -0.2236212584096826,0.3337574021162552,-0.19434031752410985,0.6919219483408452,0.46447550012638145,0.490236763907363,0.17253621044918402,1.7808852976154201,0.25375565145434276,0.1451866537146581,0.490236763907363,0.17253621044918402,-0.8777714879158465,0.5920441322650274,0.2805565672472788,0.3601597156898264,0.66712978... | 3,367 |
Coated vesicle | 21 | 83 | 2.251345 | 0.024364 | P24390,O95070,Q14108,P49755,P04439,Q5VW38,P02786,P05067,P42892,O43752,Q9Y3B3,Q9Y282,Q8N511,Q9Y5X1,O00203,P10321,P51572,Q13190,Q08379,P49257,P20645 | Localization | GO Cellular component | msigdb_gocc | 2,377,6,511,389,23,529,160,35,206,219,84,90,492,473,229,238,365,497,496,251 | 473,1869,892,3327,1315,1318,206,3221,894,2825,1807,1809,1360,377,964,1754,2055,598,529,389,160,1214,2617,229,1999,1757,816,1758,251,2,1324,35,1180,496,511,1145,2976,238,2835,2406,2501,1269,2708,3081,2836,2130,2351,2133,1535,1707,497,975,2456,365,2013,6,1538,2247,1951,2017,23,1107,90,828,1608,640,1557,1858,1614,2207,124... | 0.7656032541864601,-0.16521660034488708,0.38643153062342506,-2.131961245664126,0.11769676093724667,0.11769676093724667,1.4286699849010147,-1.4336660463047972,0.38643153062342506,-0.7794292005641262,-0.1362485904097433,-0.1362485904097433,0.09006522764362623,0.9335935466195544,0.3337574021162552,-0.1074347923116181,-0.2... | 3,367 |
Joint contracture of the hand | 12 | 57 | 2.249392 | 0.024488 | Q99741,P42892,O75844,Q8WVQ1,P16435,Q9UP83,Q8IZA0,Q71SY5,Q15392,Q9NR77,O43933,Q9UJX6 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 327,35,68,103,293,375,172,78,79,148,92,254 | 781,1170,711,3190,92,1136,2332,68,1173,1522,853,1462,293,898,3111,2702,1419,2581,2176,1820,35,1326,2661,1146,1707,3260,797,1476,728,2302,2188,79,2254,3218,1845,78,537,172,1851,103,2680,2470,1157,2960,1300,327,432,837,1792,3027,148,254,2042,375,1168,2433,1035 | 0.46447550012638145,0.19974671831673846,0.5158731784643796,-1.3251632411413339,2.294021415669942,0.22681944749468783,-0.40269627647094874,2.6926945390869426,0.19974671831673846,0.006307474011367515,0.41257400595833643,0.03437193328851483,1.0963292676298746,0.38643153062342506,-1.1488380282478365,-0.6509657620201212,0.0... | 3,367 |
Peptide binding | 20 | 71 | 2.242285 | 0.024943 | Q99735,P24390,Q8WTV0,P04439,Q8TEX9,Q9BYT8,Q9NZ08,P42892,P55899,O00264,Q9H7Z7,Q15392,Q92973,P52292,P55786,P30533,Q14978,Q9UIQ6,P10321,O14773 | Functions | GO Molecular function | msigdb_gomf | 260,2,9,389,538,151,156,35,422,304,65,79,469,466,93,225,482,228,229,108 | 594,304,527,2327,108,963,3274,2220,2394,2761,598,389,754,1214,2617,229,1930,2925,3076,2,2538,969,3240,1636,225,1143,2767,35,3185,2127,761,1702,466,2657,1703,93,422,1704,2237,1765,2133,2931,3046,2839,1537,2741,1769,2013,2016,482,79,2308,538,9,469,2555,1608,1197,260,2854,151,1400,65,1405,156,992,2607,228,3136,2485,2918 | 0.6171918880980484,1.0503522207387042,0.6919219483408452,-0.40269627647094874,2.1474158808446684,0.3337574021162552,-1.6192482414532234,-0.34234834725948426,-0.4331220969912666,-0.7148241860051961,0.6171918880980484,0.9099236880488443,0.490236763907363,0.17253621044918402,-0.5878385067985065,1.3202624041063196,-0.19434... | 3,367 |
Organophosphate ester transmembrane transporter activity | 8 | 11 | 2.234085 | 0.025478 | Q6NUK1,P41440,Q9HC21,Q9BSK2,Q99808,P12236,Q9H2D1,Q8TB61 | Functions | GO Molecular function | msigdb_gomf | 660,167,107,314,470,361,86,125 | 645,995,1040,361,167,660,125,470,314,86,107 | 0.5667757956444454,0.30722341578558393,0.2805565672472788,0.9571562106244959,1.6181799067894833,0.5667757956444454,1.9578570786990497,0.7899351985641869,1.0503522207387042,2.3657246319376566,2.165980585241542 | 3,367 |
Nucleotide transmembrane transporter activity | 8 | 11 | 2.234085 | 0.025478 | Q6NUK1,P41440,Q9HC21,Q9BSK2,Q99808,P12236,Q9H2D1,Q8TB61 | Functions | GO Molecular function | msigdb_gomf | 660,167,107,314,470,361,86,125 | 645,995,1040,361,167,660,125,470,314,86,107 | 0.5667757956444454,0.30722341578558393,0.2805565672472788,0.9571562106244959,1.6181799067894833,0.5667757956444454,1.9578570786990497,0.7899351985641869,1.0503522207387042,2.3657246319376566,2.165980585241542 | 3,367 |
Nucleotide transport | 8 | 11 | 2.234085 | 0.025478 | Q6NUK1,P41440,Q9HC21,Q9BSK2,Q99808,P12236,Q9H2D1,Q8TB61 | Processes and pathways | GO Biological process | msigdb_gobp | 660,167,107,314,470,361,86,125 | 645,995,1040,361,167,660,125,470,314,86,107 | 0.5667757956444454,0.30722341578558393,0.2805565672472788,0.9571562106244959,1.6181799067894833,0.5667757956444454,1.9578570786990497,0.7899351985641869,1.0503522207387042,2.3657246319376566,2.165980585241542 | 3,367 |
Target SNARE coiled-coil homology domain [IPR000727] | 6 | 7 | 2.226582 | 0.025975 | O15400,Q86Y82,Q12846,O43752,Q13190,O95721 | Sequence | InterPro Domain | interpro_domain | 626,459,452,206,365,122 | 626,206,122,452,365,459,678 | 0.5920441322650274,1.4286699849010147,1.9963496087227715,0.8141544886580385,0.9571562106244959,0.8141544886580385,0.5667757956444454 | 3,367 |
Transport of small molecules | 41 | 138 | 2.221249 | 0.026334 | Q15043,Q8WTV0,Q93050,P30519,P08183,P09601,Q99623,Q8IYU8,P27105,P45880,P35613,P49721,Q9Y277,P21796,Q9HD20,Q92667,Q9BUN8,Q9UJZ1,Q15904,P28070,Q658P3,P16615,P61289,P51798,Q70HW3,Q9UI12,Q9C0H2,P30825,P20618,O95202,O75027,Q9Y487,Q9UBX3,Q9UL46,O15118,O00231,Q9BU23,P12236,Q9UEY8,P28072,Q8TB61 | Processes and pathways | Reactome Pathways | msigdb_reactome | 263,9,265,16,146,21,282,150,157,29,286,36,166,34,165,298,301,317,182,306,189,305,321,71,77,341,80,85,331,330,211,358,91,356,96,345,373,361,119,252,125 | 345,2611,1921,2388,96,388,211,2647,3160,1359,1808,1809,330,2055,529,1213,995,1755,599,146,1091,1214,21,897,1215,1040,361,1882,305,788,927,1174,331,548,2897,1141,34,3058,1817,3124,3251,157,3225,306,252,1933,855,16,3125,85,2707,1046,858,2003,286,2900,1637,970,3228,2498,2620,29,1890,3060,36,724,71,1269,553,792,2236,2295,3... | 0.9806125526787869,-0.5878385067985065,-0.19434031752410985,-0.4331220969912666,2.2759315653971224,0.9099236880488443,1.3855822269020739,-0.6193116841420223,-1.2539690378581203,0.09006522764362623,-0.1362485904097433,-0.1362485904097433,1.0039634351651625,-0.2530609609086133,0.6919219483408452,0.17253621044918402,0.307... | 3,367 |
Protein transmembrane transport | 7 | 24 | 2.21993 | 0.026424 | Q9NS69,Q99595,O14925,Q15629,O60830,O43933,Q99442 | Processes and pathways | GO Biological process | msigdb_gobp | 0,37,262,11,47,92,383 | 262,376,92,47,713,2761,716,1361,1999,1462,574,511,3356,3128,1704,2237,11,2018,1601,383,37,1307,0,743 | 1.187074181061587,0.9335935466195544,2.294021415669942,3.107165693020846,0.5158731784643796,-0.7148241860051961,0.5158731784643796,0.09006522764362623,-0.2236212584096826,0.03437193328851483,0.6422200972561323,0.7165975954483155,-3.3665191515672723,-1.1836636419604167,-0.07877373131780484,-0.34234834725948426,4.1569036... | 3,367 |
serine protease | 6 | 18 | 2.215776 | 0.026707 | P67812,P10619,Q9H3G5,P42785,Q16740,Q9HB40 | Functions | Panther Protein class | panther_protein_class | 98,40,12,18,89,58 | 108,40,3072,2947,2899,1094,18,2542,98,89,395,439,2877,442,3347,12,58,3237 | 2.1474158808446684,3.227809668601115,-1.0798288811157457,-0.9109430815275097,-0.8447967022235733,0.25375565145434276,3.8282095648532786,-0.525427454868466,2.2759315653971224,2.33000339930892,0.9099236880488443,0.8382620619356581,-0.8120166279085533,0.8382620619356581,-2.559722816212025,4.144687074033624,2.8402321086925... | 3,367 |
Dicarboxylic acid transport | 6 | 15 | 2.212373 | 0.026941 | Q15041,P41440,P80404,O75746,Q9H2D1,Q9UBX3 | Processes and pathways | GO Biological process | msigdb_gobp | 295,167,234,508,86,91 | 1517,508,1873,1877,167,2236,234,1223,295,2188,1433,86,1972,91,677 | 0.006307474011367515,0.7165975954483155,-0.16521660034488708,-0.16521660034488708,1.6181799067894833,-0.34234834725948426,1.2983027806935246,0.17253621044918402,1.0963292676298746,-0.31242291199836886,0.062290731757696595,2.3657246319376566,-0.19434031752410985,2.312045215706412,0.5667757956444454 | 3,367 |
Toll like receptor signaling pathway | 8 | 19 | 2.207811 | 0.027257 | Q5KU26,O00203,P41440,Q9NQC3,P09429,Q9H1C4,Q9NPR9,P51617 | Processes and pathways | GO Biological process | msigdb_gobp | 193,473,167,106,417,174,52,307 | 473,1922,3003,3190,528,1574,417,1999,167,307,1097,2455,691,193,1282,174,52,106,1512 | 0.7656032541864601,-0.19434031752410985,-0.977885243317303,-1.3251632411413339,0.6919219483408452,-0.02190402285820215,0.862258844628111,-0.2236212584096826,1.6181799067894833,1.0503522207387042,0.25375565145434276,-0.4637180795900233,0.5413858311413456,1.471397176367932,0.1451866537146581,1.5766728741783365,2.96769748... | 3,367 |
Abnormal circulating cholesterol concentration | 14 | 33 | 2.194492 | 0.0282 | Q14739,P50402,Q9UJS0,Q15392,Q15800,Q15125,Q9NVI7,P07602,P34913,Q15904,Q13045,Q9NZJ7,Q9UBM7,Q8N511 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 289,420,677,79,110,177,503,113,181,182,216,641,185,90 | 2331,1522,1139,113,181,2125,3228,999,2804,420,2977,1146,2008,1707,654,216,1476,289,177,79,2842,110,182,1388,2510,90,1493,1116,808,503,641,185,677 | -0.40269627647094874,0.006307474011367515,0.22681944749468783,2.110076974296961,1.5137692083085525,-0.2826609847711293,-1.4336660463047972,0.30722341578558393,-0.7470323872777213,0.862258844628111,-0.9443136123937819,0.22681944749468783,-0.2236212584096826,-0.07877373131780484,0.5667757956444454,1.3855822269020739,0.03... | 3,367 |
Regulation of system process | 10 | 59 | 2.193003 | 0.028307 | P05067,P42892,O75844,P78417,P80404,Q9UQB8,P10253,Q99996,P04062,P16615 | Processes and pathways | GO Biological process | msigdb_gobp | 160,35,68,72,234,14,269,184,56,305 | 961,1357,2223,508,68,1359,2761,2616,1522,56,1212,1213,160,3006,1810,1460,269,2061,1632,3122,3288,305,927,3111,969,3125,2443,35,512,1891,1328,2501,2710,1098,72,234,3114,1273,2839,1225,606,3101,1770,2981,2014,1103,1596,866,2411,322,1112,1720,184,2202,1733,2785,1350,14,844 | 0.3337574021162552,0.09006522764362623,-0.34234834725948426,0.7165975954483155,2.6926945390869426,0.09006522764362623,-0.7148241860051961,-0.5878385067985065,0.006307474011367515,2.888427682882454,0.17253621044918402,0.17253621044918402,1.7001874873242686,-0.977885243317303,-0.1362485904097433,0.03437193328851483,1.164... | 3,367 |
Regulation of cellular ph | 7 | 19 | 2.185197 | 0.028874 | P50897,Q93050,P06576,Q9UI12,Q15904,O75503,Q8N511 | Processes and pathways | GO Biological process | msigdb_gobp | 38,265,250,341,182,57,90 | 57,814,250,3263,2704,2581,38,2235,2502,1536,182,90,803,265,828,1680,341,358,3137 | 2.8563508480242543,0.4385882859122563,1.231854696356683,-1.5816442855181783,-0.6509657620201212,-0.5565443734227432,3.2574988008466623,-0.34234834725948426,-0.49448594888254555,0.006307474011367515,1.5137692083085525,2.33000339930892,0.46447550012638145,1.187074181061587,0.4385882859122563,-0.050263952997597124,1.00396... | 3,367 |
Regulation of ph | 7 | 19 | 2.185197 | 0.028874 | P50897,Q93050,P06576,Q9UI12,Q15904,O75503,Q8N511 | Processes and pathways | GO Biological process | msigdb_gobp | 38,265,250,341,182,57,90 | 57,814,250,3263,2704,2581,38,2235,2502,1536,182,90,803,265,828,1680,341,358,3137 | 2.8563508480242543,0.4385882859122563,1.231854696356683,-1.5816442855181783,-0.6509657620201212,-0.5565443734227432,3.2574988008466623,-0.34234834725948426,-0.49448594888254555,0.006307474011367515,1.5137692083085525,2.33000339930892,0.46447550012638145,1.187074181061587,0.4385882859122563,-0.050263952997597124,1.00396... | 3,367 |
ATP synthase | 8 | 19 | 2.18493 | 0.028894 | P24539,Q93050,Q9UI12,O75964,P56385,Q15904,Q9Y487,P06576 | Functions | Panther Protein class | panther_protein_class | 378,265,341,17,214,182,358,250 | 851,17,250,548,2897,378,1580,759,2498,2928,2296,214,2502,182,427,265,947,341,358 | 0.41257400595833643,3.867353512797234,1.231854696356683,0.6671297810793578,-0.8447967022235733,0.9335935466195544,-0.02190402285820215,0.490236763907363,-0.49448594888254555,-0.8777714879158465,-0.3724389183184647,1.3855822269020739,-0.49448594888254555,1.5137692083085525,0.862258844628111,1.187074181061587,0.360159715... | 3,367 |
Abnormal leukocyte physiology | 29 | 66 | 2.169746 | 0.030026 | Q96DF8,P40763,Q14108,Q9UJS0,P09601,P02786,P13051,P19447,P21964,P48506,Q96HA7,O00754,Q9NZC9,Q15904,P04062,P28070,Q96AX1,Q13043,Q92766,P26038,Q9H0U3,O00203,Q9UJW0,P04637,P42345,P14174,Q6PGP7,Q13546,Q15833 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 130,632,6,677,21,529,649,650,285,287,831,543,447,182,56,306,828,690,733,451,622,473,104,479,601,237,770,764,380 | 473,543,2051,2335,1574,1998,1522,529,56,479,21,2762,2652,3121,649,237,967,898,2399,650,2925,3111,285,451,2400,306,2899,632,601,287,1938,1530,2708,1049,2709,1050,1224,690,764,2183,6,2460,380,182,770,871,3065,733,2552,1969,828,130,831,2316,2423,622,1562,990,447,677,104,1745,2789,1081,1988,2919 | 0.7656032541864601,0.6671297810793578,-0.2530609609086133,-0.40269627647094874,-0.02190402285820215,-0.2236212584096826,0.006307474011367515,0.6919219483408452,2.888427682882454,0.7656032541864601,3.613683844728898,-0.7148241860051961,-0.6193116841420223,-1.1836636419604167,0.5667757956444454,1.2762487791777117,0.33375... | 3,367 |
Abnormal tissue metabolite concentration | 9 | 15 | 2.165903 | 0.030319 | P06280,P06865,Q9Y276,P07602,Q9NZJ7,P56589,Q658P3,O43933,P17900 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 255,347,342,113,641,533,189,92,221 | 1454,92,713,255,347,113,2649,1634,221,1586,533,189,2845,641,342 | 0.03437193328851483,2.294021415669942,0.5158731784643796,1.2095131214680288,0.9806125526787869,2.110076974296961,-0.6193116841420223,-0.050263952997597124,1.3639014130956277,-0.02190402285820215,0.6919219483408452,1.4926272539284748,-0.7794292005641262,0.5920441322650274,1.0039634351651625 | 3,367 |
Glycerolipid metabolic process | 15 | 65 | 2.162667 | 0.030567 | Q9H490,P35790,Q9BZF1,O15228,Q92604,Q8WTV0,Q96N66,Q8NCC3,Q6IAN0,Q9UJZ1,Q99623,Q8N2K0,Q9NPH0,Q53H12,O95674 | Processes and pathways | GO Biological process | msigdb_gobp | 261,256,400,474,398,9,137,10,517,317,282,442,88,440,436 | 3158,892,2858,474,2892,1572,1264,436,3287,2120,2439,818,2582,1759,2175,256,1819,1525,1526,1821,1181,1328,1707,3114,655,1379,2014,1952,440,517,1961,585,1115,442,518,10,1342,872,9,2551,1392,398,2312,1969,1440,1609,137,805,667,2719,1158,282,1070,987,1732,913,400,1162,261,88,1309,1204,742,317,1079 | -1.2539690378581203,0.38643153062342506,-0.8120166279085533,0.7656032541864601,-0.8447967022235733,-0.02190402285820215,0.1451866537146581,0.8382620619356581,-1.695207928870715,-0.2826609847711293,-0.4637180795900233,0.4385882859122563,-0.5565443734227432,-0.1074347923116181,-0.31242291199836886,1.2095131214680288,-0.1... | 3,367 |
Carbohydrate derivative transport | 9 | 14 | 2.16109 | 0.030688 | Q6NUK1,P41440,Q8WTV0,Q9HC21,Q99808,P07602,Q9NZJ7,P12236,Q8TB61 | Processes and pathways | GO Biological process | msigdb_gobp | 660,167,9,107,470,113,641,361,125 | 3092,645,995,113,1040,361,167,2008,660,125,9,470,107,641 | -1.1142272342228774,0.5667757956444454,0.30722341578558393,2.110076974296961,0.2805565672472788,0.9571562106244959,1.6181799067894833,-0.2236212584096826,0.5667757956444454,1.9578570786990497,4.324586732934785,0.7899351985641869,2.165980585241542,0.5920441322650274 | 3,367 |
Proton transmembrane transporter activity | 10 | 31 | 2.157197 | 0.03099 | Q9Y487,P13073,Q93050,Q9UI12,Q9UDW1,O75964,P56385,O95202,Q13423,P06576 | Functions | GO Molecular function | msigdb_gomf | 358,73,265,341,112,17,214,330,278,250 | 851,17,330,718,995,250,1756,2060,1040,73,819,548,2897,378,1580,3193,759,970,2498,1889,2928,2296,214,2502,1186,278,265,1972,112,341,358 | 0.41257400595833643,3.867353512797234,1.0039634351651625,0.5158731784643796,0.30722341578558393,1.231854696356683,-0.1074347923116181,-0.2530609609086133,0.2805565672472788,2.5747617035953736,0.4385882859122563,0.6671297810793578,-0.8447967022235733,0.9335935466195544,-0.02190402285820215,-1.3251632411413339,0.49023676... | 3,367 |
Oxidoreductase activity acting on paired donors with incorporation or reduction of molecular oxygen | 10 | 31 | 2.148455 | 0.031678 | Q16850,P16435,Q6UW02,P30519,Q15800,Q6PK18,P09601,Q7LBC6,Q9BU89,Q9Y4C1 | Functions | GO Molecular function | msigdb_gomf | 131,293,200,16,110,612,21,613,384,593 | 1800,1083,3181,1994,2286,2490,2576,599,21,786,293,1581,16,1820,1331,1148,1829,938,110,131,868,1280,2365,612,200,613,384,1733,2275,2044,593 | -0.1362485904097433,0.25375565145434276,-1.2894537744189682,-0.2236212584096826,-0.3724389183184647,-0.49448594888254555,-0.5565443734227432,0.6171918880980484,3.613683844728898,0.46447550012638145,1.0963292676298746,-0.02190402285820215,3.9318663108151224,-0.1362485904097433,0.11769676093724667,0.22681944749468783,-0.... | 3,367 |
Cristae formation | 6 | 9 | 2.140829 | 0.032288 | Q5XKP0,Q9NX63,Q9BUR5,O95202,Q6UXV4,Q16891 | Processes and pathways | GO Biological process | msigdb_gobp | 581,316,412,330,121,381 | 330,381,581,121,412,1310,316,1133,644 | 1.0039634351651625,0.9335935466195544,0.6422200972561323,2.0154852262905982,0.8861457519054411,0.1451866537146581,1.0503522207387042,0.25375565145434276,0.5920441322650274 | 3,367 |
Inner mitochondrial membrane organization | 11 | 19 | 2.129933 | 0.033177 | Q13505,Q6UXV4,Q5XKP0,O60313,Q9NX63,Q9Y512,Q9BUR5,O95202,Q53H12,Q9P0J0,Q16891 | Processes and pathways | GO Biological process | msigdb_gobp | 99,121,581,359,316,644,412,330,440,386,381 | 359,2331,2761,330,3143,99,381,440,581,121,1196,412,672,1310,316,386,1133,644,2755 | 0.9571562106244959,-0.40269627647094874,-0.7148241860051961,1.0039634351651625,-1.2187064928309388,2.2759315653971224,0.9335935466195544,0.8382620619356581,0.6422200972561323,2.0154852262905982,0.19974671831673846,0.8861457519054411,0.5667757956444454,0.1451866537146581,1.0503522207387042,0.9335935466195544,0.253755651... | 3,367 |
Calcium-binding protein | 6 | 17 | 2.127706 | 0.033361 | Q14257,P80303,Q9BRK5,Q02818,Q8IYU8,P43307 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 192,1,162,54,150,28 | 243,2538,3264,28,3082,1,54,192,1007,3311,1232,150,2418,2744,948,162,1033 | 1.254099665260839,-0.525427454868466,-1.5816442855181783,3.4175453651007617,-1.0798288811157457,4.739957488800412,2.9519476787527323,1.471397176367932,0.30722341578558393,-1.889636471997411,0.17253621044918402,1.7608315718187155,-0.4331220969912666,-0.682802624960496,0.3601597156898264,1.679809873082842,0.3072234157855... | 3,367 |
Loss of speech | 7 | 20 | 2.123975 | 0.033672 | O15118,Q13501,P50897,O00754,P07602,Q9NZJ7,P17900 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 96,657,38,543,113,641,221 | 543,96,1454,2759,1808,113,1634,221,38,1328,2178,3013,1330,2008,657,728,2250,1613,641,1983 | 0.6671297810793578,2.2759315653971224,0.03437193328851483,-0.7148241860051961,-0.1362485904097433,2.110076974296961,-0.050263952997597124,1.3639014130956277,3.2574988008466623,0.11769676093724667,-0.31242291199836886,-0.977885243317303,0.11769676093724667,-0.2236212584096826,0.5667757956444454,0.5158731784643796,-0.342... | 3,367 |
Apical part of cell | 24 | 51 | 2.109745 | 0.03488 | P15311,P04083,Q15043,Q8NCM8,P08183,P35241,O75955,P05067,O75970,P41440,P54709,Q86UE4,P21281,P53985,Q15154,Q9Y4G8,Q16625,Q14254,Q16181,P26038,Q99808,P30825,Q9P289,P08238 | Localization | GO Cellular component | msigdb_gocc | 630,753,263,801,146,531,528,160,784,167,792,171,548,553,438,59,188,691,822,451,470,85,642,754 | 1990,961,1924,2219,528,784,753,1213,160,146,1091,1265,754,1215,2923,630,1042,927,548,2897,451,85,1818,531,970,2291,2498,167,553,792,2236,2449,2502,1828,1226,2361,1102,691,263,438,822,188,171,801,877,470,2159,642,3000,59,3137 | -0.2236212584096826,0.3337574021162552,-0.19434031752410985,-0.34234834725948426,0.6919219483408452,0.46447550012638145,0.490236763907363,0.17253621044918402,1.7001874873242686,1.7808852976154201,0.25375565145434276,0.1451866537146581,0.490236763907363,0.17253621044918402,-0.8777714879158465,0.5920441322650274,0.280556... | 3,367 |
Inorganic anion transmembrane transporter activity | 6 | 14 | 2.109548 | 0.034897 | Q9Y277,P21796,P51798,Q9C0H2,Q9UBX3,P45880 | Functions | GO Molecular function | msigdb_gomf | 166,34,71,80,91,29 | 2756,1454,3263,34,29,71,2236,1223,263,3206,80,91,166,3137 | -0.7148241860051961,0.03437193328851483,-1.5816442855181783,3.2722740469256966,3.403217513344748,2.6256544201008225,-0.34234834725948426,0.17253621044918402,1.187074181061587,-1.3611000187999303,2.4539090139419626,2.312045215706412,1.6388066898289295,-1.1836636419604167 | 3,367 |
Glycerophospholipid biosynthesis | 11 | 31 | 2.109527 | 0.034899 | P35790,Q9BZF1,Q92604,Q96N66,Q8NCC3,Q8IV08,Q9NQZ5,Q9NPH0,Q53H12,O95674,Q8N2A8 | Processes and pathways | Reactome Pathways | msigdb_reactome | 256,400,398,137,10,441,117,88,440,436,259 | 2858,474,2489,436,2120,2226,256,1819,1465,1821,1528,2447,2625,440,585,441,259,1720,2957,10,1342,2551,398,137,2719,3117,1070,400,88,117,742 | -0.8120166279085533,0.7656032541864601,-0.49448594888254555,0.8382620619356581,-0.2826609847711293,-0.34234834725948426,1.2095131214680288,-0.1362485904097433,0.03437193328851483,-0.1362485904097433,0.006307474011367515,-0.4637180795900233,-0.5878385067985065,0.8382620619356581,0.6422200972561323,0.8382620619356581,1.2... | 3,367 |
Absent septum pellucidum | 11 | 37 | 2.102321 | 0.035525 | Q6P1N0,O14974,Q96N66,O96028,Q71SY5,Q15392,Q2M1P5,O43505,Q2M389,O95202,Q8N3U4 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 258,231,137,236,78,79,246,87,310,330,353 | 231,711,87,2329,330,236,630,1821,2543,363,2236,1475,1895,2953,2409,1103,2073,79,246,310,258,1281,78,353,2466,1496,2556,137,1558,2816,564,1202,1129,1406,2384,2966,3250 | 1.2983027806935246,0.5158731784643796,2.3478963961729225,-0.40269627647094874,1.0039634351651625,1.2762487791777117,0.5920441322650274,-0.1362485904097433,-0.525427454868466,0.9571562106244959,-0.34234834725948426,0.03437193328851483,-0.16521660034488708,-0.9109430815275097,-0.4331220969912666,0.25375565145434276,-0.25... | 3,367 |
Protein targeting | 43 | 108 | 2.09549 | 0.036127 | Q9NS69,O43615,Q14108,O14925,Q9H9H4,P49840,Q15629,O00170,P56589,P07900,P43307,Q15005,P27105,P46379,P13473,Q5JRX3,Q99595,Q10713,Q15041,O60725,P46934,O60830,Q96RL7,Q53H12,O14964,Q7Z3B4,P31751,O14737,Q9UGP8,Q16543,O95831,O43933,P55786,O00203,P49458,P51572,Q9Y512,Q99442,P49257,Q9P0J0,P20645,P30536,O00560 | Processes and pathways | GO Biological process | msigdb_gobp | 0,376,6,262,401,512,11,268,533,648,28,406,157,30,161,658,37,655,295,170,419,47,700,440,434,584,574,205,743,729,716,92,93,473,603,238,644,383,496,386,251,124,625 | 2529,268,473,625,1515,205,262,434,376,1454,1992,92,170,47,713,2647,1629,2761,2860,2732,2056,716,1361,648,1929,1999,1757,161,2226,251,2703,157,2440,3140,124,3213,574,857,1934,2767,28,30,419,496,603,512,2235,238,93,533,3356,3128,2007,1704,2237,1705,1098,3016,1944,2739,655,1947,2456,1226,6,406,295,11,1189,729,2018,440,658... | -0.525427454868466,1.164537106940616,0.7656032541864601,0.5920441322650274,0.006307474011367515,1.4286699849010147,1.187074181061587,0.8382620619356581,0.9335935466195544,0.03437193328851483,-0.2236212584096826,2.294021415669942,1.5974688426783576,3.107165693020846,0.5158731784643796,-0.6193116841420223,-0.050263952997... | 3,367 |
Calcium ion binding | 17 | 83 | 2.095114 | 0.036161 | Q14257,P80303,Q9BRK5,O43852,O95202,Q8WVQ1,Q9Y680,Q9UM22,Q9H223,Q96AY3,P16615,Q02818,O75071,Q8IYU8,O60476,Q9Y4G8,P16455 | Functions | GO Molecular function | msigdb_gomf | 192,1,162,243,330,103,42,13,338,208,305,54,55,150,249,59,191 | 680,1354,1454,1085,243,249,55,2825,2490,508,1874,330,753,2121,2969,1697,1879,1810,2289,1320,817,3110,629,1418,1634,191,305,2439,1042,818,1321,1142,2538,1217,2766,3125,3264,2586,1465,1048,1822,3082,554,1643,1,54,973,3046,2839,1829,765,1103,1596,192,2772,1007,352,660,3148,1601,2811,2632,150,1342,1548,103,431,208,2744,445... | 0.5413858311413456,0.09006522764362623,0.03437193328851483,0.25375565145434276,1.254099665260839,1.231854696356683,2.9202924545011304,-0.7794292005641262,-0.49448594888254555,0.7165975954483155,-0.16521660034488708,1.0039634351651625,0.490236763907363,-0.2826609847711293,-0.9443136123937819,-0.07877373131780484,-0.1652... | 3,367 |
Snare interactions in vesicular transport | 8 | 11 | 2.09256 | 0.036388 | O15400,Q86Y82,Q12846,O43752,Q9P2W9,Q13190,Q9UNK0,O95721 | Processes and pathways | KEGG Pathways | msigdb_kegg | 626,459,452,206,81,365,678,122 | 626,1037,206,1807,122,452,795,365,459,81,678 | 0.5920441322650274,0.2805565672472788,1.4286699849010147,-0.1362485904097433,1.9963496087227715,0.8141544886580385,0.46447550012638145,0.9571562106244959,0.8141544886580385,2.436398337597714,0.5667757956444454 | 3,367 |
Snap receptor activity | 8 | 11 | 2.09256 | 0.036388 | O15400,Q86Y82,Q12846,O43752,Q9P2W9,Q13190,Q9UNK0,O95721 | Functions | GO Molecular function | msigdb_gomf | 626,459,452,206,81,365,678,122 | 626,1037,206,1807,122,452,795,365,459,81,678 | 0.5920441322650274,0.2805565672472788,1.4286699849010147,-0.1362485904097433,1.9963496087227715,0.8141544886580385,0.46447550012638145,0.9571562106244959,0.8141544886580385,2.436398337597714,0.5667757956444454 | 3,367 |
Metalloprotease | 6 | 24 | 2.091782 | 0.036458 | O75844,P42892,Q9BYT8,Q96KP4,Q9NZ08,P55786 | Functions | Protein Atlas Molecular function | protein_atlas_molecular_function | 68,35,151,183,156,93 | 1921,750,2647,68,403,896,2651,3121,1930,35,1589,93,658,2468,183,522,151,2377,2564,2962,2322,156,228,1133 | -0.19434031752410985,0.490236763907363,-0.6193116841420223,2.6926945390869426,0.8861457519054411,0.38643153062342506,-0.6193116841420223,-1.1836636419604167,-0.19434031752410985,3.2722740469256966,-0.02190402285820215,2.294021415669942,0.5667757956444454,-0.4637180795900233,1.5137692083085525,0.7165975954483155,1.76083... | 3,367 |
Atpase coupled transmembrane transporter activity | 6 | 17 | 2.089625 | 0.036652 | Q9HD20,P51798,P08183,O75027,P06576,P16615 | Functions | GO Molecular function | msigdb_gomf | 165,71,146,211,250,305 | 963,211,1213,250,146,305,927,548,2897,855,970,2498,71,2502,165,1509,341 | 0.3337574021162552,1.3855822269020739,0.17253621044918402,1.231854696356683,1.7808852976154201,1.0503522207387042,0.3601597156898264,0.6671297810793578,-0.8447967022235733,0.41257400595833643,0.3337574021162552,-0.49448594888254555,2.6256544201008225,-0.49448594888254555,1.6388066898289295,0.03437193328851483,1.0039634... | 3,367 |
Endocytic vesicle | 25 | 82 | 2.077693 | 0.037738 | O15400,Q14108,Q8WTV0,Q93050,P08670,P04439,Q9UNK0,P02786,P13473,Q9Y5K6,Q9H1C4,O00461,Q9Y4G8,Q16625,O14964,Q5KU26,Q86Y82,Q12846,O43752,Q9H223,Q9Y487,P10321,P01889,P42345,P20645 | Localization | GO Cellular component | msigdb_gocc | 626,6,9,265,390,389,678,529,161,570,174,51,59,188,434,193,459,452,206,338,358,229,598,601,251 | 2529,1990,2486,51,434,626,963,206,3221,3004,1807,1809,2055,598,529,389,648,390,1214,2617,229,1577,1039,816,161,1418,1758,251,2538,1044,757,601,1145,1822,1182,2235,2976,1269,2449,2836,2129,2130,2502,3267,2133,1535,1707,3046,452,2456,2013,1770,2981,6,691,1381,2247,2411,2077,188,1954,193,1107,1385,2599,459,9,2421,265,1608... | -0.525427454868466,-0.2236212584096826,-0.49448594888254555,2.983395828585835,0.8382620619356581,0.5920441322650274,0.3337574021162552,1.4286699849010147,-1.4336660463047972,-0.977885243317303,-0.1362485904097433,-0.1362485904097433,-0.2530609609086133,0.6171918880980484,0.6919219483408452,0.9099236880488443,0.56677579... | 3,367 |
Delusions | 9 | 22 | 2.072182 | 0.038248 | Q96DF8,Q9BQE5,Q9UJS0,Q96RL7,O00754,P07602,Q9NZJ7,P04062,P21964 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 130,3,677,700,543,113,641,56,285 | 543,1454,56,113,2799,1634,285,2582,2291,999,2126,1585,1898,2015,3065,130,700,3,777,641,2568,677 | 0.6671297810793578,0.03437193328851483,2.888427682882454,2.110076974296961,-0.7470323872777213,-0.050263952997597124,1.1191654406700127,-0.5565443734227432,-0.3724389183184647,0.30722341578558393,-0.2826609847711293,-0.02190402285820215,-0.16521660034488708,-0.2236212584096826,-1.0456406280505959,1.9384991366690936,0.5... | 3,367 |
Signaling | 9 | 17 | 2.067641 | 0.038674 | P43490,Q96PC5,Q96GC9,Q99627,P42166,O00264,O15173,Q8WUJ1,Q13123 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 257,832,875,446,333,304,118,312,796 | 304,118,1358,2340,333,257,2006,1833,796,1106,1546,312,875,910,832,446,1680 | 1.0503522207387042,2.0535377021037875,0.09006522764362623,-0.40269627647094874,1.0039634351651625,1.2095131214680288,-0.2236212584096826,-0.1362485904097433,0.46447550012638145,0.25375565145434276,0.006307474011367515,1.0503522207387042,0.41257400595833643,0.38643153062342506,0.4385882859122563,0.8382620619356581,-0.05... | 3,367 |
Submucous cleft of soft and hard palate | 8 | 26 | 2.064424 | 0.038978 | Q99741,Q96DF8,O75844,Q9Y2W2,Q15392,Q7LGA3,Q2M1P5,O43505 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 327,130,68,343,79,239,246,87 | 2283,711,87,68,1522,2399,2583,1821,687,1766,2872,1475,3101,1054,1103,1275,79,246,1845,239,353,3065,130,327,343,3250 | -0.3724389183184647,0.5158731784643796,2.3478963961729225,2.6926945390869426,0.006307474011367515,-0.4331220969912666,-0.5565443734227432,-0.1362485904097433,0.5413858311413456,-0.1074347923116181,-0.8120166279085533,0.03437193328851483,-1.1142272342228774,0.2805565672472788,0.25375565145434276,0.1451866537146581,2.471... | 3,367 |
Mitochondrial nucleotide transporter subfamily | 6 | 9 | 2.060683 | 0.039333 | Q6NUK1,Q9HC21,Q70HW3,Q9BSK2,P12236,Q9H2D1 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 660,107,77,314,361,86 | 645,995,1040,361,660,77,314,86,107 | 0.5667757956444454,0.30722341578558393,0.2805565672472788,0.9571562106244959,0.5667757956444454,2.5060688955133497,1.0503522207387042,2.3657246319376566,2.165980585241542 | 3,367 |
Abnormality of the 5th toe | 6 | 7 | 2.059777 | 0.03942 | Q14739,Q10713,Q9Y263,Q2M1P5,Q9UBM7,Q8IYA6 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 289,655,173,246,185,634 | 655,289,246,634,801,185,173 | 0.5667757956444454,1.1191654406700127,1.254099665260839,0.5920441322650274,0.46447550012638145,1.5137692083085525,1.5974688426783576 | 3,367 |
Dementia | 12 | 61 | 2.059411 | 0.039455 | P05067,P06865,Q13510,Q14108,O15118,O60313,P07602,Q9NQZ5,P35637,P04062,Q9Y487,P17900 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 160,347,101,6,96,359,113,117,332,56,358,221 | 747,96,1454,359,2052,628,1361,718,56,3276,2121,160,347,113,2861,2862,1634,221,1175,2001,2341,1635,756,3142,2865,332,970,2498,999,1423,1328,2178,3013,2008,2356,1100,1273,2359,657,101,6,865,2250,1777,1012,1115,871,1392,520,2780,1344,700,1611,3314,117,641,387,1624,2889,358,2918 | 0.490236763907363,2.2759315653971224,0.03437193328851483,0.9571562106244959,-0.2530609609086133,0.5920441322650274,0.09006522764362623,0.5158731784643796,2.888427682882454,-1.6192482414532234,-0.2826609847711293,1.7001874873242686,0.9806125526787869,2.110076974296961,-0.8120166279085533,-0.8120166279085533,-0.050263952... | 3,367 |
Abnormality of the septum pellucidum | 13 | 47 | 2.049906 | 0.040374 | Q6P1N0,O14974,Q96N66,O96028,Q71SY5,Q15392,P53701,Q2M1P5,Q9UJX6,O43505,Q2M389,O95202,Q8N3U4 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 258,231,137,236,78,79,363,246,254,87,310,330,353 | 231,711,87,2329,330,236,630,2581,1526,1821,2543,363,2236,1475,1895,2953,2409,1103,2073,1275,79,246,310,1903,258,1281,78,353,1390,2466,1496,2556,1157,137,3069,432,1558,2816,564,1202,1129,1406,2384,254,2966,2919,3250 | 1.2983027806935246,0.5158731784643796,2.3478963961729225,-0.40269627647094874,1.0039634351651625,1.2762487791777117,0.5920441322650274,-0.5565443734227432,0.006307474011367515,-0.1362485904097433,-0.525427454868466,0.9571562106244959,-0.34234834725948426,0.03437193328851483,-0.16521660034488708,-0.9109430815275097,-0.4... | 3,367 |
Lipase activity | 7 | 17 | 2.048397 | 0.040521 | Q9H6V9,Q8NCC3,Q8IV08,Q8NHP8,P09601,Q8N2K0,Q8N2A8 | Functions | GO Molecular function | msigdb_gomf | 67,10,441,49,21,442,259 | 3159,21,818,1759,1044,3228,3133,441,1115,259,442,518,10,49,67,1204,1684 | -1.2539690378581203,3.613683844728898,0.4385882859122563,-0.1074347923116181,0.2805565672472788,-1.4336660463047972,-1.1836636419604167,0.8382620619356581,0.25375565145434276,1.2095131214680288,0.8382620619356581,0.7165975954483155,4.301006972369739,3.045680587864037,2.709311108656073,0.19974671831673846,-0.05026395299... | 3,367 |
Hexosyltransferase activity | 13 | 32 | 2.04804 | 0.040556 | Q10471,Q10472,Q9BT22,P06865,Q13126,P04844,P04843,O43505,Q96L58,Q6ZXV5,P04062,Q2TAA5,P46977 | Functions | GO Molecular function | msigdb_gomf | 654,308,292,347,41,719,572,87,410,149,56,222,686 | 1800,709,87,2286,1572,2825,56,572,719,1139,347,2649,1812,1041,1935,3229,686,1148,2356,654,308,41,222,149,1285,1286,1235,908,410,292,2157,1739 | -0.1362485904097433,0.5158731784643796,2.3478963961729225,-0.3724389183184647,-0.02190402285820215,-0.7794292005641262,2.888427682882454,0.6422200972561323,0.5158731784643796,0.22681944749468783,0.9806125526787869,-0.6193116841420223,-0.1362485904097433,0.2805565672472788,-0.19434031752410985,-1.4336660463047972,0.5413... | 3,367 |
Establishment of protein localization to vacuole | 8 | 18 | 2.040755 | 0.041275 | P13473,O00203,Q9H9H4,Q14108,P46934,Q9BRG1,P20645,O14964 | Processes and pathways | GO Biological process | msigdb_gobp | 161,473,401,6,419,638,251,434 | 473,1515,434,1757,161,251,419,2235,6,1012,942,1602,700,1158,638,401,3157,918 | 0.7656032541864601,0.006307474011367515,0.8382620619356581,-0.1074347923116181,1.679809873082842,1.231854696356683,0.862258844628111,-0.34234834725948426,4.383005400114565,0.30722341578558393,0.3601597156898264,-0.02190402285820215,0.5413858311413456,0.22681944749468783,0.5920441322650274,0.9099236880488443,-1.21870649... | 3,367 |
Endocytic vesicle membrane | 10 | 40 | 2.038007 | 0.041549 | P13473,Q5KU26,Q14108,P10321,Q93050,Q8WTV0,Q12846,P04439,Q9Y487,P20645 | Localization | GO Cellular component | msigdb_gocc | 161,193,6,229,265,9,452,389,358,251 | 2486,963,1807,1809,2055,598,529,389,229,1039,816,161,1758,251,2538,1145,2235,1269,2836,2129,2502,2133,1535,1707,3046,452,1770,2981,6,2247,2411,193,1385,9,265,1608,1158,1910,2042,358 | -0.49448594888254555,0.3337574021162552,-0.1362485904097433,-0.1362485904097433,-0.2530609609086133,0.6171918880980484,0.6919219483408452,0.9099236880488443,1.3202624041063196,0.2805565672472788,0.4385882859122563,1.679809873082842,-0.1074347923116181,1.231854696356683,-0.525427454868466,0.22681944749468783,-0.34234834... | 3,367 |
Hydrogen ion transport | 7 | 18 | 2.03162 | 0.042192 | Q93050,Q9UI12,O75964,P56385,Q15904,Q9Y487,P06576 | Processes and pathways | Protein Atlas Biological process | protein_atlas_biological_process | 265,341,17,214,182,358,250 | 851,17,250,548,2897,378,1580,759,970,2498,2928,2296,214,2502,182,265,341,358 | 0.41257400595833643,3.867353512797234,1.231854696356683,0.6671297810793578,-0.8447967022235733,0.9335935466195544,-0.02190402285820215,0.490236763907363,0.3337574021162552,-0.49448594888254555,-0.8777714879158465,-0.3724389183184647,1.3855822269020739,-0.49448594888254555,1.5137692083085525,1.187074181061587,1.00396343... | 3,367 |
Hydrolase activity acting on glycosyl bonds | 11 | 33 | 2.028273 | 0.042532 | P06280,P16278,O60476,P04066,P54802,P10253,O00462,P04062,O75503,P17900,O60502 | Functions | GO Molecular function | msigdb_gomf | 255,5,249,319,109,269,180,56,57,221,62 | 180,543,2488,249,62,57,56,319,255,347,2649,269,2699,649,5,221,1176,3140,899,1935,109,2547,2356,2183,2593,610,1282,2084,3358,1730,1028,2964,3002 | 1.5137692083085525,0.6671297810793578,-0.49448594888254555,1.231854696356683,2.7588221406548605,2.8563508480242543,2.888427682882454,1.0272097103903832,1.2095131214680288,0.9806125526787869,-0.6193116841420223,1.164537106940616,-0.6509657620201212,0.5667757956444454,4.4292036485047825,1.3639014130956277,0.1997467183167... | 3,367 |
Reductase | 6 | 16 | 2.024665 | 0.042902 | Q9H7Z7,Q9UDW1,Q15392,O95881,Q9UBM7,P00374 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 65,112,79,82,185,63 | 3301,1359,1876,82,63,2923,2763,2864,652,1178,289,79,2845,65,185,112 | -1.8110727649287937,0.09006522764362623,-0.16521660034488708,2.418824969229302,2.7588221406548605,-0.8777714879158465,-0.7148241860051961,-0.8120166279085533,0.5667757956444454,0.19974671831673846,1.1191654406700127,2.471357400586925,-0.7794292005641262,2.742374563169135,1.5137692083085525,2.1287815015903986 | 3,367 |
Transmembrane transport | 57 | 187 | 2.023318 | 0.04304 | Q9NS69,P24539,O43615,O14925,Q15043,Q8WTV0,Q15629,O75964,P08183,Q99623,Q8IYU8,Q13423,P45880,P27105,P05067,Q99595,Q9Y277,P21796,Q9HD20,P41440,Q15041,O43772,O60830,Q9UHG3,Q9UJZ1,Q6NT16,Q9BSK2,P04062,Q99996,P16615,Q16625,O75844,Q8IXU6,P51798,P78417,P13073,Q70HW3,P23786,Q9UI12,Q9C0H2,P56385,Q8NE01,P30825,Q9H2D1,P35754,O9520... | Processes and pathways | GO Biological process | msigdb_gobp | 0,378,376,262,263,9,11,17,146,282,150,278,29,157,160,37,166,34,165,167,295,169,47,48,317,178,314,56,184,305,188,68,70,71,72,73,77,207,341,80,214,335,85,86,213,330,211,91,92,97,107,369,112,361,250,383,125 | 3092,1990,2756,1746,961,262,376,1085,169,645,92,2118,47,1517,211,3200,2758,2793,713,2647,508,68,1873,851,17,2761,330,545,2575,716,1361,718,56,1213,160,995,1877,250,1697,1879,1810,146,1091,1756,3263,2060,1999,1215,1462,1632,1040,361,73,305,818,927,819,548,2897,3111,34,207,378,1580,157,3140,969,855,3240,3125,85,574,3193,... | -1.1142272342228774,-0.2236212584096826,-0.7148241860051961,-0.1074347923116181,0.3337574021162552,1.187074181061587,0.9335935466195544,0.25375565145434276,1.5974688426783576,0.5667757956444454,2.294021415669942,-0.2826609847711293,3.107165693020846,0.006307474011367515,1.3855822269020739,-1.3611000187999303,-0.7148241... | 3,367 |
Abnormal epiphyseal ossification | 13 | 17 | 2.016799 | 0.043716 | Q14739,P56589,O00116,Q14807,Q96HA7,Q15125,Q9UG56,Q2M1P5,Q96HY6,Q96L58,Q9UBM7,O43933,O75381 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 289,533,571,821,831,177,742,246,281,410,185,92,713 | 571,92,3004,713,897,1366,533,289,821,177,2842,246,831,281,410,185,742 | 0.6422200972561323,2.294021415669942,-0.977885243317303,0.5158731784643796,0.38643153062342506,0.09006522764362623,0.6919219483408452,1.1191654406700127,0.4385882859122563,1.5348236972160396,-0.7794292005641262,1.254099665260839,0.4385882859122563,1.1419011221151822,0.8861457519054411,1.5137692083085525,0.5158731784643... | 3,367 |
Regulation of hormone levels | 16 | 59 | 2.016466 | 0.043751 | Q53GQ0,Q8N183,P42892,O75844,Q15043,P16435,P80404,Q12846,P17858,P53985,O95563,Q9UBM7,Q9HB40,O95470,P30536,Q14849 | Processes and pathways | GO Biological process | msigdb_gobp | 351,129,35,68,263,293,234,452,495,553,545,185,58,123,124,31 | 1990,1516,1995,1927,68,123,545,2492,753,1213,1265,1930,2763,293,495,2002,124,3125,1819,35,3279,1181,1586,553,3014,2660,2665,234,3114,2839,452,1895,3101,1770,31,263,1277,1952,1190,351,582,1385,2599,2415,129,1017,1237,1604,2030,2603,1020,701,3314,3152,58,185,2967,643,2281 | -0.2236212584096826,0.006307474011367515,-0.2236212584096826,-0.19434031752410985,2.6926945390869426,1.9771403969263128,0.6671297810793578,-0.49448594888254555,0.490236763907363,0.17253621044918402,0.1451866537146581,-0.19434031752410985,-0.7148241860051961,1.0963292676298746,0.7411577066416265,-0.2236212584096826,1.97... | 3,367 |
Organelle membrane contact site | 6 | 14 | 2.014946 | 0.04391 | Q5XKP0,Q96N66,P51572,Q96TC7,A0FGR8,Q14849 | Localization | GO Cellular component | msigdb_gocc | 581,137,238,313,680,31 | 680,1995,1361,1217,238,31,581,1292,1293,137,313,1158,1309,780 | 0.5413858311413456,-0.2236212584096826,0.09006522764362623,0.17253621044918402,1.2762487791777117,3.3454673481684774,0.6422200972561323,0.1451866537146581,0.1451866537146581,1.8603105982788577,1.0503522207387042,0.22681944749468783,0.1451866537146581,0.490236763907363 | 3,367 |
Exaggerated startle response | 6 | 9 | 2.011816 | 0.044239 | P06865,P16278,Q9Y263,Q00577,P08243,P17900 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 347,5,173,535,154,221 | 347,2649,154,5,221,535,703,1308,173 | 0.9806125526787869,-0.6193116841420223,1.7406977485275759,4.4292036485047825,1.3639014130956277,0.6919219483408452,0.5413858311413456,0.1451866537146581,1.5974688426783576 | 3,367 |
Trans golgi network membrane | 8 | 24 | 2.011513 | 0.044271 | P05067,Q9UP83,P53367,O43752,Q9UID3,P53365,P20645,O15127 | Localization | GO Cellular component | msigdb_gocc | 160,375,141,206,542,147,251,435 | 847,435,1318,206,2219,160,1214,816,251,576,147,141,1183,2836,1826,1535,1894,2411,1482,2266,1557,542,375,2789 | 0.41257400595833643,0.8382620619356581,0.11769676093724667,1.4286699849010147,-0.34234834725948426,1.7001874873242686,0.17253621044918402,0.4385882859122563,1.231854696356683,0.6422200972561323,1.7808852976154201,1.820754742930303,0.19974671831673846,-0.7794292005641262,-0.1362485904097433,0.006307474011367515,-0.16521... | 3,367 |
Establishment of protein localization to membrane | 26 | 82 | 2.010098 | 0.044421 | Q9NS69,Q9H9H4,Q15629,P56589,P43307,P27105,P46379,Q96A33,Q9HD20,Q15041,O60725,Q15904,Q4J6C6,Q53H12,P31751,Q9Y276,O14737,Q9H4A6,O15118,O00203,P49458,Q9Y512,Q99442,Q15070,Q9P0J0,O00560 | Processes and pathways | GO Biological process | msigdb_gobp | 0,401,11,533,28,157,30,431,165,295,170,182,439,440,574,342,205,471,96,473,603,644,383,366,386,625 | 2529,473,625,205,1315,96,1454,1992,170,3159,1629,2761,1264,648,1929,2703,157,2290,3213,574,1934,2767,1584,28,30,2622,603,2235,1329,533,3356,3128,2836,1704,2129,2237,3216,935,1947,2456,2549,1480,295,2188,366,11,182,439,1842,440,2307,1658,1601,1602,1193,1547,1848,1196,431,1344,383,1910,2425,1125,471,1402,401,165,2207,0,8... | -0.525427454868466,0.7656032541864601,0.5920441322650274,1.4286699849010147,0.11769676093724667,2.2759315653971224,0.03437193328851483,-0.2236212584096826,1.5974688426783576,-1.2539690378581203,-0.050263952997597124,-0.7148241860051961,0.1451866537146581,0.5667757956444454,-0.19434031752410985,-0.6509657620201212,1.720... | 3,367 |
Positive regulation of peptidase activity | 18 | 43 | 2.009594 | 0.044474 | P05067,Q9Y255,P40763,Q96A26,Q9NR28,P61289,Q9BXK5,P09429,P42575,O14737,P51572,P61604,Q92542,Q9NZJ7,Q96HY6,O95831,Q9P0J0,Q9UL46 | Processes and pathways | GO Biological process | msigdb_gobp | 160,100,632,132,196,321,374,417,549,205,238,605,218,641,281,716,386,356 | 1869,1921,1922,205,1357,2825,1873,2054,716,1574,160,417,1999,1176,632,549,1938,238,3013,321,605,3145,3216,1429,1829,2013,1005,2671,218,1019,132,1609,773,281,877,374,196,641,386,1407,1863,356,100 | -0.16521660034488708,-0.19434031752410985,-0.19434031752410985,1.4286699849010147,0.09006522764362623,-0.7794292005641262,-0.16521660034488708,-0.2530609609086133,0.5158731784643796,-0.02190402285820215,1.7001874873242686,0.862258844628111,-0.2236212584096826,0.19974671831673846,0.5920441322650274,0.6671297810793578,-0... | 3,367 |
Protein targeting to vacuole | 6 | 17 | 2.001836 | 0.045302 | P13473,Q9H9H4,Q14108,P46934,P20645,O14964 | Processes and pathways | GO Biological process | msigdb_gobp | 161,401,6,419,251,434 | 473,1515,434,1757,161,251,419,2235,6,1012,942,1602,700,1158,401,3157,918 | 0.7656032541864601,0.006307474011367515,0.8382620619356581,-0.1074347923116181,1.679809873082842,1.231854696356683,0.862258844628111,-0.34234834725948426,4.383005400114565,0.30722341578558393,0.3601597156898264,-0.02190402285820215,0.5413858311413456,0.22681944749468783,0.9099236880488443,-1.2187064928309388,0.38643153... | 3,367 |
Serine protease | 9 | 30 | 2.001058 | 0.045386 | P67812,P10619,Q2T9J0,Q9H3G5,O14773,Q86UT6,P42785,P34913,Q9HB40 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 98,40,395,12,108,370,18,181,58 | 2216,108,40,2947,2899,181,1094,18,2542,1703,1002,932,98,1895,2774,2904,395,2877,370,442,3347,2469,1395,1908,12,58,1862,3237,2110,2114 | -0.34234834725948426,2.1474158808446684,3.227809668601115,-0.9109430815275097,-0.8447967022235733,1.5137692083085525,0.25375565145434276,3.8282095648532786,-0.525427454868466,-0.07877373131780484,0.30722341578558393,0.3601597156898264,2.2759315653971224,-0.16521660034488708,-0.7148241860051961,-0.8447967022235733,0.909... | 3,367 |
Cell recognition | 8 | 26 | 1.995608 | 0.045977 | P05067,Q14157,Q5KU26,Q8WTV0,Q9NQC3,P50991,P45880,P35613 | Processes and pathways | GO Biological process | msigdb_gobp | 160,288,193,9,106,392,29,286 | 2530,1354,2729,3292,160,2340,2122,451,286,3165,29,2804,2404,2868,392,1944,1333,2071,288,193,1280,9,1393,2154,106,1795 | -0.525427454868466,0.09006522764362623,-0.682802624960496,-1.7335697222803168,1.7001874873242686,-0.40269627647094874,-0.2826609847711293,0.8141544886580385,1.1191654406700127,-1.2539690378581203,3.403217513344748,-0.7470323872777213,-0.4331220969912666,-0.8120166279085533,0.9099236880488443,-0.19434031752410985,0.1176... | 3,367 |
Transporter | 73 | 171 | 1.99528 | 0.046012 | O15400,P24539,P24390,Q9BQE5,Q15043,Q93050,P49755,O75746,Q00765,Q9UJS0,Q9UPT5,P08183,Q8TEX9,Q9UNK0,P13473,Q6NUK1,Q9UNZ2,O43808,Q9P253,Q12768,P41440,O43772,O60749,O60664,O95563,Q6NT16,P21281,Q9BSK2,Q92973,P53985,O00471,P16615,Q9C0E2,Q7Z3B4,Q86Y82,Q8IXU6,Q12846,Q70HW3,O43752,Q9UI12,Q9P2W9,P56385,Q9Y3B3,Q8N1F7,P30825,Q9H2D... | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 626,378,2,3,263,265,511,508,515,677,274,146,538,678,161,660,296,645,567,656,167,169,416,415,545,178,548,314,469,553,681,305,592,584,459,70,452,77,206,341,81,214,219,334,85,86,470,330,622,211,91,358,221,466,366,608,226,497,473,250,107,238,367,114,365,641,640,361,496,122,625,125,380 | 1990,473,681,625,2327,3327,1515,2328,1805,626,206,682,169,645,1135,415,2394,416,894,211,1627,508,851,1360,330,1753,964,1754,545,122,1361,1213,995,250,146,1091,1214,2617,1215,1039,1040,361,161,305,221,927,548,2897,2,378,1580,855,1886,85,1324,759,2975,2498,167,1180,1528,496,511,238,466,2657,1590,2835,2406,1269,553,2708,2... | -0.2236212584096826,0.7656032541864601,0.5413858311413456,0.5920441322650274,-0.40269627647094874,-2.131961245664126,0.006307474011367515,-0.40269627647094874,-0.1362485904097433,0.5920441322650274,1.4286699849010147,0.5413858311413456,1.5974688426783576,0.5667757956444454,0.22681944749468783,0.862258844628111,-0.43312... | 3,367 |
Organic hydroxy compound biosynthetic process | 10 | 58 | 1.992184 | 0.046351 | Q14739,Q16850,Q13510,Q15392,Q15800,Q15125,P04062,Q9UBM7,Q9Y4G8,P00374 | Processes and pathways | GO Biological process | msigdb_gobp | 289,131,101,79,110,177,56,185,59,63 | 3158,2116,2048,2328,448,1317,1625,1808,63,3182,56,2057,2438,1632,1633,293,2829,2002,2579,855,2582,2803,2619,2125,2769,930,1763,2349,2660,1331,3231,1050,1226,101,3019,938,289,177,2985,79,2842,110,1952,131,1609,1344,1241,3314,3152,880,1245,2104,1203,185,2483,1512,59,3250 | -1.2539690378581203,-0.2826609847711293,-0.2530609609086133,-0.40269627647094874,0.8141544886580385,0.11769676093724667,-0.050263952997597124,-0.1362485904097433,2.7588221406548605,-1.2894537744189682,2.888427682882454,-0.2530609609086133,-0.4637180795900233,-0.050263952997597124,-0.050263952997597124,1.096329267629874... | 3,367 |
Myoclonus | 15 | 98 | 1.990073 | 0.046583 | P05067,Q13510,P50897,Q14108,P13073,Q9UBX3,O14773,P07602,Q9NQZ5,Q9NPL8,P04062,O75503,Q9Y4G8,P00374,Q96CU9 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 160,101,38,6,73,91,108,113,117,152,56,57,59,63,126 | 1746,2824,108,1991,2613,849,57,2396,2335,896,3222,1361,63,718,56,3276,160,113,2438,1215,73,1699,548,2735,756,2174,3142,1143,3226,2975,2498,999,2232,3265,2348,38,1328,2659,2869,1330,1705,2625,535,1535,168,904,1536,2838,2839,655,2873,3168,101,765,6,2809,2984,728,1482,2844,662,2845,1064,1848,1660,563,126,1608,1725,773,263... | -0.1074347923116181,-0.7794292005641262,2.1474158808446684,-0.2236212584096826,-0.5878385067985065,0.41257400595833643,2.8563508480242543,-0.4331220969912666,-0.40269627647094874,0.38643153062342506,-1.4336660463047972,0.09006522764362623,2.7588221406548605,0.5158731784643796,2.888427682882454,-1.6192482414532234,1.700... | 3,367 |
Phospholipase activity | 6 | 15 | 1.985991 | 0.047034 | Q8NCC3,Q8NHP8,Q8IV08,P09601,Q8N2K0,Q8N2A8 | Functions | GO Molecular function | msigdb_gomf | 10,49,441,21,442,259 | 3159,21,818,1759,1044,3133,441,1115,259,442,518,10,49,1204,1684 | -1.2539690378581203,3.613683844728898,0.4385882859122563,-0.1074347923116181,0.2805565672472788,-1.1836636419604167,0.8382620619356581,0.25375565145434276,1.2095131214680288,0.8382620619356581,0.7165975954483155,4.301006972369739,3.045680587864037,0.19974671831673846,-0.050263952997597124 | 3,367 |
Cellular monovalent inorganic cation homeostasis | 7 | 23 | 1.984955 | 0.047149 | P50897,Q93050,P06576,Q9UI12,Q15904,O75503,Q8N511 | Processes and pathways | GO Biological process | msigdb_gobp | 38,265,250,341,182,57,90 | 57,814,1213,250,3263,2704,2581,38,2235,792,2236,2502,1536,182,90,803,265,828,521,1680,341,358,3137 | 2.8563508480242543,0.4385882859122563,0.17253621044918402,1.231854696356683,-1.5816442855181783,-0.6509657620201212,-0.5565443734227432,3.2574988008466623,-0.34234834725948426,0.46447550012638145,-0.34234834725948426,-0.49448594888254555,0.006307474011367515,1.5137692083085525,2.33000339930892,0.46447550012638145,1.187... | 3,367 |
Purine containing compound transmembrane transport | 6 | 7 | 2.972144 | 0.002957 | P12236,P12235,O43808,P41440,Q8TB61,Q99808 | Processes and pathways | GO Biological process | msigdb_gobp | 319,382,416,305,90,220 | 416,468,382,319,305,90,220 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,2.3801413717832185,1.466931925297071 | 3,367 |
Glycosyl hydrolase, all-beta [IPR013780] | 6 | 9 | 2.955604 | 0.003121 | P08195,O00754,P04066,P10253,Q16706,P06280 | Sequence | InterPro Superfamily | interpro_homologous_superfamily | 228,304,151,215,255,158 | 304,151,158,228,215,2102,1465,255,318 | 1.215113641326997,1.8662479062047552,1.8176890567881447,1.4220394712306121,1.4963055376015855,-0.26016766358371546,0.08693242005995136,1.3449116360969309,1.1983035605965535 | 3,367 |
Nucleotide transmembrane transport | 7 | 8 | 2.93364 | 0.00335 | Q9H2D1,P12236,P12235,O43808,Q9BSK2,P41440,Q8TB61 | Processes and pathways | GO Biological process | msigdb_gobp | 34,319,382,416,148,305,90 | 416,468,382,319,305,90,148,34 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,2.3801413717832185,1.8781863881212548,2.890625351614288 | 3,367 |
Sphingolipid metabolism | 6 | 9 | 2.921946 | 0.003479 | P07602,O95470,Q13510,P04062,P17900,Q06136 | Processes and pathways | Protein Atlas Biological process | protein_atlas_biological_process | 96,168,105,77,142,118 | 187,1057,168,77,96,142,118,105,422 | 1.6638074968049952,0.2951830560010072,1.7423415075038748,2.4825951976483345,2.335383722636951,1.9251598438788062,2.0803344644041046,2.2029718745769076,0.9479222361894882 | 3,367 |
Other glycan degradation | 6 | 8 | 2.898091 | 0.003754 | P16278,P04062,O00462,O00754,P04066,P06865 | Processes and pathways | KEGG Pathways | msigdb_kegg | 99,77,181,304,151,159 | 181,304,77,151,159,556,99,318 | 1.6771266142603685,1.215113641326997,2.4825951976483345,1.8662479062047552,1.8176890567881447,0.729124255274676,2.2705311632252636,1.1983035605965535 | 3,367 |
Cherry red spot of the macula | 6 | 9 | 2.857998 | 0.004263 | P07602,P16278,Q13510,P17900,P10619,P06865 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 96,99,105,142,25,159 | 159,96,556,25,2616,99,142,105,226 | 1.8176890567881447,2.335383722636951,0.729124255274676,3.026194883421824,-0.6219282991061461,2.2705311632252636,1.9251598438788062,2.2029718745769076,1.4371162851533967 | 3,367 |
Membrane lipid catabolic process | 8 | 12 | 2.842069 | 0.004482 | P50897,Q13510,P04062,P17900,Q99735,P04066,P06280,P06865 | Processes and pathways | GO Biological process | msigdb_gobp | 37,105,77,142,47,151,158,159 | 168,77,151,158,159,556,142,37,1787,105,47,506 | 1.7423415075038748,2.4825951976483345,1.8662479062047552,1.8176890567881447,1.8176890567881447,0.729124255274676,1.9251598438788062,2.8270698998630386,-0.08100355533358121,2.2029718745769076,2.7047036631931967,0.8111494097674319 | 3,367 |
Intermembrane lipid transfer | 6 | 9 | 2.800412 | 0.005104 | P30536,P48739,Q9Y255,P61916,Q14849,Q00169 | Processes and pathways | GO Biological process | msigdb_gobp | 38,425,333,207,52,376 | 1520,38,425,207,376,52,484,1335,333 | 0.05967638946816246,2.8205477650693105,0.9288874484851392,1.539559092295675,1.0407059867495412,2.6760044811975723,0.8312040210401753,0.167024418688523,1.164275250038993 | 3,367 |
Lipid transfer activity | 6 | 9 | 2.800412 | 0.005104 | P30536,P48739,Q9Y255,P61916,Q14849,Q00169 | Functions | GO Molecular function | msigdb_gomf | 38,425,333,207,52,376 | 1520,38,425,207,376,52,484,1335,333 | 0.05967638946816246,2.8205477650693105,0.9288874484851392,1.539559092295675,1.0407059867495412,2.6760044811975723,0.8312040210401753,0.167024418688523,1.164275250038993 | 3,367 |
Mitochondrial nucleotide transporter subfamily | 7 | 9 | 2.761559 | 0.005753 | Q9H2D1,P12236,Q70HW3,P12235,O43808,Q9BSK2,Q9HC21 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 34,319,5,382,416,148,390 | 416,468,382,319,885,5,148,34,390 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,0.41711587127886296,3.42761454357412,1.8781863881212548,2.890625351614288,1.0224610166287966 | 3,367 |
Abnormality of the 5th toe | 6 | 7 | 2.75856 | 0.005806 | Q10713,Q8IYA6,Q2M1P5,Q9UBM7,Q14739,Q9Y263 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 384,500,395,373,88,155 | 384,88,395,500,651,373,155 | 1.0224610166287966,2.397693896936502,1.004062193335618,0.8111494097674319,0.6223339421703995,1.0587990871720139,1.8421311359067558 | 3,367 |
Purine nucleotide transmembrane transporter activity | 6 | 8 | 2.741056 | 0.006124 | P12236,P12235,O43808,P41440,Q8TB61,Q99808 | Functions | GO Molecular function | msigdb_gomf | 319,382,416,305,90,220 | 416,468,382,319,305,885,90,220 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,0.41711587127886296,2.3801413717832185,1.466931925297071 | 3,367 |
Purine nucleotide transport | 6 | 8 | 2.741056 | 0.006124 | P12236,P12235,O43808,P41440,Q8TB61,Q99808 | Processes and pathways | GO Biological process | msigdb_gobp | 319,382,416,305,90,220 | 416,468,382,319,305,885,90,220 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,0.41711587127886296,2.3801413717832185,1.466931925297071 | 3,367 |
Sphingolipid metabolism | 6 | 11 | 2.728916 | 0.006354 | P16278,O95470,Q13510,P04062,Q06136,P06280 | Processes and pathways | KEGG Pathways | msigdb_kegg | 99,168,105,77,118,158 | 187,1057,1292,168,77,158,869,99,118,105,506 | 1.6638074968049952,0.2951830560010072,0.167024418688523,1.7423415075038748,2.4825951976483345,1.8176890567881447,0.41711587127886296,2.2705311632252636,2.0803344644041046,2.2029718745769076,0.8111494097674319 | 3,367 |
Antiporter activity | 7 | 9 | 2.727303 | 0.006385 | P12236,P12235,P08195,O95202,Q9UBX3,P51798,P41440 | Functions | GO Molecular function | msigdb_gomf | 319,382,228,423,113,176,305 | 423,468,228,382,319,305,176,880,113 | 0.9288874484851392,0.8510828673242099,1.4220394712306121,1.0224610166287966,1.1813579964049232,1.215113641326997,1.7034857241216244,0.41711587127886296,2.12221644874816 | 3,367 |
Nucleotide transport | 9 | 11 | 2.700307 | 0.006928 | Q9H2D1,P12236,P12235,O43808,Q9BSK2,P41440,Q8TB61,Q99808,Q9HC21 | Processes and pathways | GO Biological process | msigdb_gobp | 34,319,382,416,148,305,90,220,390 | 416,468,382,319,305,885,90,220,148,34,390 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,0.41711587127886296,2.3801413717832185,1.466931925297071,1.8781863881212548,2.890625351614288,1.0224610166287966 | 3,367 |
Organophosphate ester transmembrane transporter activity | 9 | 11 | 2.700307 | 0.006928 | Q9H2D1,P12236,P12235,O43808,Q9BSK2,P41440,Q8TB61,Q99808,Q9HC21 | Functions | GO Molecular function | msigdb_gomf | 34,319,382,416,148,305,90,220,390 | 416,468,382,319,305,885,90,220,148,34,390 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,0.41711587127886296,2.3801413717832185,1.466931925297071,1.8781863881212548,2.890625351614288,1.0224610166287966 | 3,367 |
Nucleotide transmembrane transporter activity | 9 | 11 | 2.700307 | 0.006928 | Q9H2D1,P12236,P12235,O43808,Q9BSK2,P41440,Q8TB61,Q99808,Q9HC21 | Functions | GO Molecular function | msigdb_gomf | 34,319,382,416,148,305,90,220,390 | 416,468,382,319,305,885,90,220,148,34,390 | 0.9479222361894882,0.8510828673242099,1.0224610166287966,1.1813579964049232,1.215113641326997,0.41711587127886296,2.3801413717832185,1.466931925297071,1.8781863881212548,2.890625351614288,1.0224610166287966 | 3,367 |
Intrinsic component of golgi membrane | 7 | 8 | 2.672251 | 0.007534 | Q9Y282,O15258,O95070,Q10471,Q6ZRP7,Q8TB61,O43505 | Localization | GO Cellular component | msigdb_gocc | 58,570,199,328,409,90,222 | 662,570,222,199,328,409,90,58 | 0.6003808098842504,0.7081536166136876,1.4520800003016594,1.5957748152355407,1.164275250038993,0.9667948763063292,2.3801413717832185,2.6168313220680655 | 3,367 |
Sterol transporter activity | 6 | 10 | 2.658261 | 0.007855 | Q9BZF1,Q96SU4,P30536,P61916,Q14849,O15118 | Functions | GO Molecular function | msigdb_gomf | 484,483,38,207,52,62 | 62,1520,38,207,52,483,1710,484,1335,567 | 2.5940067345114333,0.05967638946816246,2.8205477650693105,1.539559092295675,2.6760044811975723,0.8312040210401753,-0.02383226339257427,0.8312040210401753,0.167024418688523,0.729124255274676 | 3,367 |
SNARE protein | 6 | 8 | 2.621449 | 0.008756 | Q13190,O95721,Q9P2W9,O15400,Q12846,O43752 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 512,444,109,642,435,189 | 642,189,444,435,512,1541,109,703 | 0.6223339421703995,1.636885011245724,0.8903227193980846,0.9096883453244767,0.7909166148274583,0.05967638946816246,2.142774273043244,0.5782226275951864 | 3,367 |
SNARE protein | 6 | 8 | 2.621449 | 0.008756 | Q13190,O95721,Q9P2W9,O15400,Q12846,O43752 | Functions | Panther Protein class | panther_protein_class | 512,444,109,642,435,189 | 642,189,444,435,512,1541,109,703 | 0.6223339421703995,1.636885011245724,0.8903227193980846,0.9096883453244767,0.7909166148274583,0.05967638946816246,2.142774273043244,0.5782226275951864 | 3,367 |
Glycosaminoglycan metabolism | 7 | 12 | 2.612975 | 0.008976 | P16278,P15586,Q7LGA3,Q8TB61,P54802,O43505,P06865 | Processes and pathways | Reactome Pathways | msigdb_reactome | 99,131,164,90,123,222,159 | 1351,222,1573,159,556,131,99,123,164,90,396,1497 | 0.1406019790514642,1.4520800003016594,0.03213342001996372,1.8176890567881447,0.729124255274676,1.9933637465889655,2.2705311632252636,2.059000402859114,1.7678013879954078,2.3801413717832185,1.004062193335618,0.08693242005995136 | 3,367 |
Osteoarthritis | 6 | 11 | 2.529138 | 0.011434 | Q8WVQ1,P04062,O75844,P51798,P01889,Q14108 | Drugs and Diseases | Human Phenotype Ontology | msigdb_hp | 195,77,79,176,370,27 | 933,79,370,1355,77,176,27,1792,195,610,413 | 0.36905959273700245,2.4743130323893365,1.0587990871720139,0.1406019790514642,2.4825951976483345,1.7034857241216244,2.997900374043612,-0.08100355533358121,1.6232795468280017,0.6656366965541234,0.9667948763063292 | 3,367 |
Calmodulin | 8 | 13 | 2.519482 | 0.011753 | Q9BRK5,Q8N163,O43852,Q02818,Q8IYU8,P31949,P80303,Q14257 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 128,191,194,66,233,241,24,154 | 194,241,2539,24,66,154,1794,3139,1961,233,191,276,128 | 1.6232795468280017,1.3915412079886775,-0.5526559048046669,3.031779563764609,2.578591270907004,1.8542297642204297,-0.08100355533358121,-1.2856723173605489,-0.16911056369956773,1.4220394712306121,1.636885011245724,1.2971892954417479,2.0264935421031782 | 3,367 |
Intracellular calcium-sensing protein | 8 | 13 | 2.519482 | 0.011753 | Q9BRK5,Q8N163,O43852,Q02818,Q8IYU8,P31949,P80303,Q14257 | Drugs and Diseases | Pharos Drug Target Ontology | pharos_dto | 128,191,194,66,233,241,24,154 | 194,241,2539,24,66,154,1794,3139,1961,233,191,276,128 | 1.6232795468280017,1.3915412079886775,-0.5526559048046669,3.031779563764609,2.578591270907004,1.8542297642204297,-0.08100355533358121,-1.2856723173605489,-0.16911056369956773,1.4220394712306121,1.636885011245724,1.2971892954417479,2.0264935421031782 | 3,367 |
Glycoside hydrolase superfamily [IPR017853] | 10 | 16 | 2.499921 | 0.012422 | O60502,P16278,P08195,P04062,O00462,P04066,P10253,P54802,P06280,P06865 | Sequence | InterPro Superfamily | interpro_homologous_superfamily | 65,99,228,77,181,151,215,123,158,159 | 181,65,77,151,158,159,556,228,215,99,1299,123,2102,1465,318,800 | 1.6771266142603685,2.578591270907004,2.4825951976483345,1.8662479062047552,1.8176890567881447,1.8176890567881447,0.729124255274676,1.4220394712306121,1.4963055376015855,2.2705311632252636,0.167024418688523,2.059000402859114,-0.26016766358371546,0.08693242005995136,1.1983035605965535,0.4874788724810751 | 3,367 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.